Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 209307

Expand all

DEXMEDETOMIDINE HYDROCHLORIDE (DEXMEDETOMIDINE HYDROCHLORIDE)
EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)
Marketing Status: Prescription
Active Ingredient: DEXMEDETOMIDINE HYDROCHLORIDE
Proprietary Name: DEXMEDETOMIDINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A209307
Product Number: 001
Approval Date: Jun 3, 2020
Applicant Holder Full Name: GLAND PHARMA LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
DEXMEDETOMIDINE HYDROCHLORIDE (DEXMEDETOMIDINE HYDROCHLORIDE)
EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
Marketing Status: Prescription
Active Ingredient: DEXMEDETOMIDINE HYDROCHLORIDE
Proprietary Name: DEXMEDETOMIDINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A209307
Product Number: 002
Approval Date: Jun 3, 2020
Applicant Holder Full Name: GLAND PHARMA LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English